From January 4, 2024 to March 31, 2024, the company has repurchased 2,025,200 shares, representing 0.23% for CNY 40 million. With this, the company has completed the repurchase of 2,025,200 shares, representing 0.23% for CNY 40 million under the buyback announced on January 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.36 CNY | -1.45% | +1.49% | -32.42% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.42% | 2.04B | |
+30.38% | 684B | |
+29.78% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+15.95% | 240B | |
+9.36% | 208B | |
-7.32% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024.